Literature DB >> 29604089

Electrocardiographic left ventricular hypertrophy predicts recurrence of atrial arrhythmias after catheter ablation of paroxysmal atrial fibrillation.

Song-Nan Li1, Lu Wang1, Jian-Zeng Dong1, Rong-Hui Yu1, De-Yong Long1, Ri-Bo Tang1, Cai-Hua Sang1, Chen-Xi Jiang1, Nian Liu1, Rong Bai1, Xin Du1, Chang-Sheng Ma1.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) is an independent predictor of new-onset atrial fibrillation. Whether LVH can predict the recurrence of arrhythmia after radiofrequency catheter ablation (RFCA) in patients with paroxysmal atrial fibrillation (PAF) remains unclear. HYPOTHESIS: PAF patients with baseline-electrocardiographic LVH has a higher recurrence rate after RFCA procedure compared with those without LVH.
METHODS: A total of 436 patients with PAF undergoing first RFCA were consecutively enrolled and clustered into 2 groups based on electrocardiogram (ECG) findings: non-ECG LVH (218 patients) and ECG LVH (218 patients). LVH was characterized by the Romhilt-Estes point score system; the score ≥5points were defined as LVH.
RESULTS: At 42 months' (interquartile range, 18.0-60.0 months) follow-up after RFCA, 151 (69.3%) patients in the non-ECG LVH group and 108 (49.5%) patients in the ECG LVH group maintained sinus rhythm without using antiarrhythmic drugs (P < 0.001). Patients with ECG LVH tended to experience a much higher prevalence of stroke and recurrence of atrial arrhythmia episodes compared with those without ECG LVH (log-rank P < 0.001). Multivariate analysis found the presence of ECG LVH and left atrial diameter to be independent risk factors for recurrence after adjusting for confounding factors.
CONCLUSIONS: The presence of ECG LVH was a strong and independent predictor of recurrence in patients with PAF following RFCA.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Atrial Fibrillation; Electrocardiogram; Left Ventricular Hypertrophy; Radiofrequency Catheter Ablation

Mesh:

Substances:

Year:  2018        PMID: 29604089      PMCID: PMC6490114          DOI: 10.1002/clc.22957

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  14 in total

1.  Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Jonathan Chrispin; Aditya Jain; Elsayed Z Soliman; Eliseo Guallar; Alvaro Alonso; Susan R Heckbert; David A Bluemke; João A C Lima; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

2.  Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation.

Authors:  Caroline Medi; Jonathan M Kalman; Steven J Spence; Andrew W Teh; Geoffrey Lee; Ilona Bader; David M Kaye; Peter M Kistler
Journal:  J Cardiovasc Electrophysiol       Date:  2011-07-07

3.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

4.  Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy.

Authors:  Apurva O Badheka; Neeraj Shah; Peeyush M Grover; Nileshkumar J Patel; Ankit Chothani; Kathan Mehta; Vikas Singh; Abhishek Deshmukh; Ghanshyambhai T Savani; Ankit Rathod; Sidakpal S Panaich; Nilay Patel; Shilpkumar Arora; Vipulkumar Bhalara; James O Coffey; Raul D Mitrani; Jonathan L Halperin; Juan F Viles-Gonzalez
Journal:  Am J Cardiol       Date:  2014-01-14       Impact factor: 2.778

5.  Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Giuseppe Di Pasquale; Giovanni Mazzotta; Giuseppe Ambrosio; Sean Yang; Janice Pogue; Lars Wallentin; Michael D Ezekowitz; Stuart J Connolly; Salim Yusuf
Journal:  Am J Cardiol       Date:  2013-11-23       Impact factor: 2.778

6.  Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy.

Authors:  Neeraj Shah; Apurva O Badheka; Peeyush M Grover; Nileshkumar J Patel; Ankit Chothani; Kathan Mehta; Michael Hoosien; Vikas Singh; Ghanshyambhai T Savani; Abhishek Deshmukh; Ankit Rathod; Nilay Patel; Sidakpal S Panaich; Shilpkumar Arora; Charles Schwartz; Martin Blisker; James O Coffey; Raul D Mitrani; Valentin Fuster; Juan F Viles-Gonzalez
Journal:  Int J Cardiol       Date:  2014-04-13       Impact factor: 4.164

7.  Single-catheter technique for pulmonary vein antrum isolation: is it sufficient to identify and close the residual gaps without a circular mapping catheter?

Authors:  Jianzeng Dong; Xingpeng Liu; Deyong Long; Ronghui Yu; Ribo Tang; Fei Lü; Changsheng Ma
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-13

8.  Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.

Authors:  Mehmet Akkaya; Koji Higuchi; Matthias Koopmann; Nathan Burgon; Ercan Erdogan; Kavitha Damal; Eugene Kholmovski; Chris McGann; Nassir F Marrouche
Journal:  Europace       Date:  2013-05-27       Impact factor: 5.214

9.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.

Authors:  Kristian Wachtell; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Kristian Thygesen
Journal:  Circulation       Date:  2007-07-30       Impact factor: 29.690

10.  Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance.

Authors:  Stefan Buchner; Kurt Debl; Josef Haimerl; Behrus Djavidani; Florian Poschenrieder; Stefan Feuerbach; Guenter A J Riegger; Andreas Luchner
Journal:  J Cardiovasc Magn Reson       Date:  2009-06-01       Impact factor: 5.364

View more
  8 in total

1.  Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.

Authors:  Vibhu Parcha; Nirav Patel; Rajat Kalra; Joonseok Kim; Orlando M Gutiérrez; Garima Arora; Pankaj Arora
Journal:  Hypertension       Date:  2020-05-04       Impact factor: 10.190

2.  New Radiomic Markers of Pulmonary Vein Morphology Associated With Post-Ablation Recurrence of Atrial Fibrillation.

Authors:  Michael A Labarbera; Thomas Atta-Fosu; Albert K Feeny; Marjan Firouznia; Meghan Mchale; Catherine Cantlay; Tyler Roach; Alexis Axtell; Paul Schoenhagen; John Barnard; Jonathan D Smith; David R Van Wagoner; Anant Madabhushi; Mina K Chung
Journal:  IEEE J Transl Eng Health Med       Date:  2021-12-09

3.  Electrocardiographic left ventricular hypertrophy predicts recurrence of atrial arrhythmias after catheter ablation of paroxysmal atrial fibrillation.

Authors:  Song-Nan Li; Lu Wang; Jian-Zeng Dong; Rong-Hui Yu; De-Yong Long; Ri-Bo Tang; Cai-Hua Sang; Chen-Xi Jiang; Nian Liu; Rong Bai; Xin Du; Chang-Sheng Ma
Journal:  Clin Cardiol       Date:  2018-06-05       Impact factor: 2.882

4.  Transient manifestation of left ventricular diastolic dysfunction following ablation in patients with paroxysmal atrial fibrillation.

Authors:  Tomoko Minamisaka; Tetsuya Watanabe; Yukinori Shinoda; Kuniyasu Ikeoka; Hidetada Fukuoka; Hirooki Inui; Keisuke Ueno; Soki Inoue; Kentaro Mine; Shiro Hoshida
Journal:  Clin Cardiol       Date:  2018-07-18       Impact factor: 2.882

5.  Machine Learning-Derived Fractal Features of Shape and Texture of the Left Atrium and Pulmonary Veins From Cardiac Computed Tomography Scans Are Associated With Risk of Recurrence of Atrial Fibrillation Postablation.

Authors:  Marjan Firouznia; Albert K Feeny; Michael A LaBarbera; Meghan McHale; Catherine Cantlay; Natalie Kalfas; Paul Schoenhagen; Walid Saliba; Patrick Tchou; John Barnard; Mina K Chung; Anant Madabhushi
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

6.  Relationship between serum angiopoietin-like 4 levels and recurrence of atrial fibrillation.

Authors:  Zhongping Ning; Xinming Li; Xi Zhu; Jun Luo; Yingbiao Wu
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

Review 7.  The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome.

Authors:  Hsiang-Chun Lee; Yi-Hsiung Lin
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

8.  Increased red blood cell distribution width might predict left ventricular hypertrophy in patients with atrial fibrillation.

Authors:  Hui-Ming Yao; Xiao-Lei Wang; Xiong Peng; Shu-Yun Chen; Xuan Wan; Wei Zuo; Xin Gan
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.